Sign In
Buy NVRO
$5.84
+0 (+0%)
At Close: Jul 01, 2025
Nevro Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
12:00pm, Thursday, 02'nd Apr 2020
Nevro Corp. ("Nevro") (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the pricing of concurrent
Here's a roundup of top developments in the biotech space over the last 24 hours.On a day when the three major averages shed over 4% in reaction to bleak forecasts concerning the COVID-19 pandemic's
Analysts Offer Insights on Healthcare Companies: Nevro Crop (NVRO), Inspire Medical Systems (INSP) and AxoGen (AXGN)
10:16am, Thursday, 02'nd Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Nevro Crop (NVRO), Inspire Medical Systems (INSP) and AxoGen (AXGN).
Analysts Offer Insights on Healthcare Companies: Nevro Crop (NYSE: NVRO), Inspire Medical Systems (NYSE: INSP) and AxoGen (NASDAQ: AXGN)
10:16am, Thursday, 02'nd Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Nevro Crop (NVRO – Research
Nevro (NYSE:NVRO) Trading 0.1% Higher
09:12am, Thursday, 02'nd Apr 2020
Nevro Corp (NYSE:NVRO)’s share price traded up 0.1% during trading on Tuesday . The company traded as high as $99.76 and last traded at $98.51, 18,200 shares were traded during mid-day trading. A de
Nevro Corp (NYSE:NVRO) Short Interest Update
08:16am, Thursday, 02'nd Apr 2020
Nevro Corp (NYSE:NVRO) was the target of a significant growth in short interest in March. As of March 13th, there was short interest totalling 2,539,800 shares, a growth of 10.9% from the February 27t
JP Morgan Maintains Neutral on Nevro, Lowers Price Target to $90
12:00am, Thursday, 02'nd Apr 2020BRIEF-Nevro Says Commenced Proposed Offering Of 1.63 Mln Shares Of Common Stock And $165 Mln Of Convertible Senior Notes Due 2025
08:59pm, Wednesday, 01'st Apr 2020
Nevro Corp:
Nevro Announces Proposed Public Offering of Common Stock and Convertible Senior Notes
08:40pm, Wednesday, 01'st Apr 2020
Nevro Corp. ("Nevro") (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that it has commenced a pr
Nevro issues Q1 and FY2020 update
08:30pm, Wednesday, 01'st Apr 2020
Nevro (NYSE:NVRO) reports preliminary Q1 2020 revenue is expected to be ~$86.4M - $86.9M, up 5-6% Y/Y; says Q1 revenue was negatively impacted by a rapid deceleration in March due to COVID-19 shelter-
New York, April 01, 2020 -- Reportlinker.com announces the release of the report "Global Transcutaneous Electrical Nerve Stimulation Market - Premium Insight, Competitive News.
BRIEF-Nevro Sees Q1 2020 Revenue Between $86.4 Mln And $86.9 Mln
08:13pm, Wednesday, 01'st Apr 2020
Nevro Corp:
Nevro Provides First Quarter and FY2020 Update
08:07pm, Wednesday, 01'st Apr 2020
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced preliminary unaudited worldwide reve
